Aflac Incorporated
Financials
Valuation Metrics
Aflac Incorporated's Market Cap is $63.42B. At end of 2025 it was $58.14B. Ranked #269 of 3,116 in US market (top 9%), #196 of 1,644 on NYSE (top 12%), #11 of 93 in Insurance (top 12%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $63.42B | US#269/3,116 Sec#11/93 |
| Revenue | $18.09B | US#351/3,116 Sec#17/93 |
| Net Income | $4.86B | US#150/3,116 Sec#5/93 |
| Total Assets | $115.96B | US#154/3,116 Sec#18/93 |
| Net Assets | $30.31B | US#158/3,116 Sec#7/93 |
| Employees | 12,716 | US#758/3,116 Sec#24/93 |
| Value | ||
| P/E | 13.04x | US#596/3,116 Sec#51/93 |
| P/B | 2.09x | US#1,312/3,116 Sec#60/93 |
| PEG | 0.13x | US#235/3,116 Sec#18/93 |
| P/S | 3.51x | US#1,901/3,116 Sec#77/93 |
| EV/EBITDA | 9.57x | US#725/3,116 Sec#50/93 |
| FCF Yield | 4.17% | US#1,549/3,116 Sec#80/93 |
| Profitability | ||
| ROE | 16.04% | US#808/3,116 Sec#39/93 |
| ROA | 4.19% | US#1,189/3,116 Sec#36/93 |
| Op. Margin | 32.16% | US#455/3,116 Sec#14/93 |
| Revenue Growth | 11.62% | US#1,114/3,116 Sec#31/93 |
| Earnings Growth | 99.51% | US#299/3,116 Sec#17/93 |
| Financial Health | ||
| Debt Ratio | 282.56% | US#2,055/3,116 Sec#36/93 |
| Total Debt | $8.73B | US#455/3,116 Sec#12/93 |
| FCF | $2.65B | US#290/3,116 Sec#22/93 |
| Cash | $6.12B | US#168/3,116 Sec#10/93 |
| Current Ratio | 11.31x | US#215/3,116 Sec#20/93 |
| Net Debt/EBITDA | 0.38x | US#739/3,116 Sec#47/93 |
| Dividend | ||
| Div. Yield | 1.88% | US#965/3,116 Sec#38/93 |
| Div. Growth | 16.00% | US#319/3,116 Sec#7/93 |
| Performance | ||
| 1Y Return | 17.48% | US#1,237/3,116 Sec#40/93 |
| 1M Return | 11.72% | US#856/3,116 Sec#36/93 |
| From 52W High | -4.31% | US#480/3,116 Sec#33/93 |
| 1Y MDD | -14.18% | US#219/3,116 Sec#20/93 |
| Trading | ||
| Volume | 1,340,801 shares | US#1,406/3,116 Sec#22/93 |
| Trading Value | $166M | US#722/3,116 Sec#17/93 |
| Per Share | ||
| EPS | $9.55 | US#316/3,116 Sec#29/93 |
| BPS | $59.55 | US#316/3,116 Sec#33/93 |
Company Info
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.